Groundbreaking cancer treatment may trigger more cancer – but here’s why you shouldn’t worry
The risk of getting a secondary cancer after Car-T cell therapy is low, a new study confirms.
The risk of getting a secondary cancer after Car-T cell therapy is low, a new study confirms.
Liver transplants could offer hope to patients with difficult to treat, advanced bowel cancer.
Cancer death rates in the UK have hit a record low, but the picture is more complicated than the headline figure suggests.
While lung cancer rates have decreased by 43% in men, they have risen by 79% in women. New screening guidelines and recognizing early symptoms can help address the changing face of lung cancer.
The reason that nanoparticles hold such hope for TB treatment is that they can be carefully targeted.
New research suggests people who eat organic plant foods have a reduction in risk of common cancers.
Mouth cancer cases in England and Scotland have rocketed, and smoking, alcohol and HPV are likely to blame.
Understanding inflammation is one of the biggest challenges of modern medicine.
DNA and mRNA vaccines produce a different kind of immune response than traditional vaccines, allowing researchers to tackle some previously unsolvable problems in medicine.
Experts give us a science preview for 2022, plus what lies in store for global inequality. Listen to The Conversation Weekly podcast.